Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vaccine Supply Would Be Monitored By HHS Unit Under Rep. Crowley Bill

Executive Summary

A vaccine oversight agency within HHS would be established under a bill introduced by Rep. Joseph Crowley (D-N.Y.)

You may also be interested in...

Drug Discontinuation Requirements Would Be Expanded Under DeWine Bill

Manufacturers that intend to discontinue drugs or biologics would have to notify FDA even if the products to be discontinued are multi-source, under a bill introduced by Sen. Mike DeWine (D-Ohio)

GAO Vaccine Report To Address Long-Term Supply Issues

Vaccine manufacturers' reasons for exiting the market will be among the vaccine supply issues addressed in an upcoming General Accounting Office report

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts